by admin | Feb 10, 2016 | Archive
February 10, 2016 The Pharmaceutical Research and Manufacturers of America (PhRMA) is unveiling a series of new advertisements to highlight the stories of its patients and researchers. Four new ads will hit digital, print, radio, and social media channels in 2016 as... by admin | Feb 10, 2016 | Archive
February 10, 2016 CVS Health’s fourth-quarter profit increased 13% due in large part to acquisitions, and company executives said Tuesday that they expect to reap more gains from their deal making later this year. CVS Health spent more than $10 billion to buy... by admin | Feb 10, 2016 | Archive
February 10, 2016 Patients with type 2 diabetes could benefit from evolocumab, a PCSK9 inhibitor that has been shown to reduce LDL cholesterol, according to a new study. Researchers analyzed three clinical trials made up of 413 patients with type 2 diabetes and 2,119... by admin | Feb 10, 2016 | Archive
February 10, 2016 Emergency department personnel often administer ketamine for procedural sedation of young patients, but analysis suggests that children older than 13 years are more likely to experience adverse respiratory and airway events with this anesthetic... by admin | Feb 10, 2016 | Archive
February 10, 2016 The ongoing opioid epidemic has put pharmacists in an especially tough position, pulled between patients in dire need of relief and addicts who will stop at nothing to get their hands on the drugs. More than 4 million Americans abuse opioid... by admin | Feb 10, 2016 | Archive
February 10, 2016 Health insurers Cigna and Aetna separately confirmed that the price they pay for sacubitril/valsartan (Entresto—Novartis) will be determined by how well the new heart drug works. It was shown in clinical trials to reduce hospitalizations as well as...